The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post–PD-1 failure in advanced melanoma: Real-world outcomes with lenvatinib-based versus non-lenvatinib-based therapy.
 
Kristina Orlova
Honoraria - BioCad; Pierre Fabre; Roche/Genentech; Swixx BioPharma
Research Funding - BioCad (Inst)
 
Angelina Akhmetianova
Honoraria - BIOCAD; Roche
 
Mariya Cheporova
No Relationships to Disclose
 
Ekaterina Chursina
No Relationships to Disclose
 
Lev Demidov
Honoraria - BIOCAD; Novartis; Pierre Fabre; R-Pharm; Swixx BioPharma
Consulting or Advisory Role - BIOCAD
Speakers' Bureau - BIOCAD; Novartis; Pierre Fabre; Swixx BioPharma
Expert Testimony - BIOCAD
 
Igor Samoylenko
Honoraria - BioCad; Novartis; Pierre Fabre; R-Pharm; Roche; Swixx BioPharma
Speakers' Bureau - BioCad; Novartis; Pierre Fabre; R-Pharm; Roche; Swixx BioPharma
Research Funding - BioCad (Inst); CureVac (Inst); Gene Surgery (Inst); Novartis (Inst); R-Pharm (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BioCad; Roche